Osteolysis and cancer.
作者信息
Goltzman D
机构信息
Calcium Research Laboratory, Department of Medicine, McGill University Health Center, and Departments of Medicine and Physiology, McGill University, Montreal, Quebec Canada.
出版信息
J Clin Invest. 2001 May;107(10):1219-20. doi: 10.1172/JCI13073.
Abstract
摘要
相似文献
1
Osteolysis and cancer.骨质溶解与癌症。
J Clin Invest. 2001 May;107(10):1219-20. doi: 10.1172/JCI13073.
2
[[From metastatic osteolysis a painful message: beginning to understand with osteoprotegerin?].[来自转移性骨溶解的痛苦信号：骨保护素能否带来新的理解？]
Bull Cancer. 2000 Sep;87(9):623-4.
3
Bone cancer pain and the role of RANKL/OPG.骨癌疼痛与核因子κB受体活化因子配体/骨保护素的作用
J Musculoskelet Neuronal Interact. 2004 Sep;4(3):293-300.
4
Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis.疾病机制：骨保护素（OPG）、核因子κB受体活化因子配体（RANKL）和核因子κB受体活化因子（RANK）在骨转移病理生理学中的作用
Nat Clin Pract Oncol. 2006 Jan;3(1):41-9. doi: 10.1038/ncponc0381.
5
Revisiting the seed and soil theory of bone metastasis: new tools, same answer.重新审视骨转移的种子与土壤理论：新工具，相同答案。
J Musculoskelet Neuronal Interact. 2004 Dec;4(4):375-6.
6
Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone.可溶性核因子κB受体激活剂Fc可减轻前列腺癌在骨中的进展。
Cancer Res. 2003 Nov 15;63(22):7883-90.
7
Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.骨与软组织巨细胞瘤的表型及分子研究
Hum Pathol. 2005 Sep;36(9):945-54. doi: 10.1016/j.humpath.2005.07.005.
8
Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening.关节成形术膜来源的成纤维细胞在无菌性松动中直接诱导破骨细胞形成和骨溶解。
J Orthop Res. 2005 May;23(3):511-9. doi: 10.1016/j.orthres.2004.10.006. Epub 2005 Jan 19.
9
[Osteoprotegrin and RANKL/RANK system: is it the future of bone metabolism?].[骨保护素与RANKL/RANK系统：它会是骨代谢的未来吗？]
An Med Interna. 2002 Aug;19(8):385-88.
10
A novel therapeutic vaccine approach, targeting RANKL, prevents bone destruction in bone-related disorders.一种针对核因子κB受体活化因子配体（RANKL）的新型治疗性疫苗方法可预防骨相关疾病中的骨质破坏。
J Bone Miner Metab. 2002;20(5):266-8. doi: 10.1007/s007740200038.
引用本文的文献
1
The role and applications of extracellular vesicles in osteoporosis.细胞外囊泡在骨质疏松症中的作用和应用。
Bone Res. 2024 Jan 23;12(1):4. doi: 10.1038/s41413-023-00313-5.
2
BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions.BCMA 和 CST6 特异性 CAR T 细胞可溶解多发性骨髓瘤细胞并抑制鼠溶骨性病变。
J Clin Invest. 2024 Jan 2;134(1):e171396. doi: 10.1172/JCI171396.
3
Brown tumors in nuclear medicine: a systematic review.核医学中的棕色瘤：一项系统综述。
Ann Nucl Med. 2023 May;37(5):255-270. doi: 10.1007/s12149-023-01832-1. Epub 2023 Mar 18.
4
Phosphonate-Modified Cellulose Nanocrystals Potentiate the Th1 Polarising Capacity of Monocyte-Derived Dendritic Cells via GABA-B Receptor.膦酸酯修饰的纤维素纳米晶通过 GABA-B 受体增强单核细胞来源的树突状细胞的 Th1 极化能力。
Int J Nanomedicine. 2022 Jul 23;17:3191-3216. doi: 10.2147/IJN.S362038. eCollection 2022.
5
Regulated macrophage immune microenvironment in 3D printed scaffolds for bone tumor postoperative treatment.用于骨肿瘤术后治疗的3D打印支架中受调控的巨噬细胞免疫微环境
Bioact Mater. 2022 May 2;19:474-485. doi: 10.1016/j.bioactmat.2022.04.028. eCollection 2023 Jan.
6
Differentiating Co-Delivery of Bisphosphonate and Simvastatin by Self-Healing Hyaluronan Hydrogel Formed by Orthogonal "Clicks": An In-Vitro Assessment.通过正交“点击”形成的自修复透明质酸水凝胶实现双膦酸盐和辛伐他汀的差异化共递送：体外评估
Polymers (Basel). 2021 Jun 26;13(13):2106. doi: 10.3390/polym13132106.
7
Tumor Suppressive Effects of miR-124 and Its Function in Neuronal Development.miR-124的肿瘤抑制作用及其在神经元发育中的功能
Int J Mol Sci. 2021 May 31;22(11):5919. doi: 10.3390/ijms22115919.
8
Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling Pathways.齐墩果酸抑制去卵巢诱导的骨质疏松症和破骨细胞生成，调节RANKL介导的NF-κb和Nfatc1信号通路。
Front Pharmacol. 2020 Mar 27;11:331. doi: 10.3389/fphar.2020.00331. eCollection 2020.
9
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma.缺氧激活前药埃伏非司他与促凋亡受体激动剂联合用于骨肉瘤的抗癌疗效增强。
Cancer Med. 2017 Sep;6(9):2164-2176. doi: 10.1002/cam4.1115. Epub 2017 Aug 10.
10
The influence of genetic variability and proinflammatory status on the development of bone disease in patients with Gaucher disease.遗传变异性和促炎状态对戈谢病患者骨病发展的影响。
PLoS One. 2015 May 15;10(5):e0126153. doi: 10.1371/journal.pone.0126153. eCollection 2015.
本文引用的文献
1
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.骨保护素抑制前列腺癌诱导的破骨细胞生成，并防止前列腺肿瘤在骨中生长。
J Clin Invest. 2001 May;107(10):1235-44. doi: 10.1172/JCI11685.
2
The molecular basis of osteoclast differentiation and activation.破骨细胞分化与激活的分子基础。
Novartis Found Symp. 2001;232:235-47; discussion 247-50. doi: 10.1002/0470846658.ch16.
3
Biochemical markers of bone formation in patients with plasma cell dyscrasias and benign osteoporosis.浆细胞异常增生症和良性骨质疏松症患者的骨形成生化标志物。
Clin Chem. 2001 Apr;47(4):686-93.
4
Molecular mechanisms of tumor-bone interactions in osteolytic metastases.溶骨性转移中肿瘤与骨相互作用的分子机制
Crit Rev Eukaryot Gene Expr. 2000;10(2):159-78.
5
Osteoprotegerin ligand: a regulator of immune responses and bone physiology.骨保护素配体：免疫反应和骨生理学的调节因子。
Immunol Today. 2000 Oct;21(10):495-502. doi: 10.1016/s0167-5699(00)01718-7.
6
Cellular and molecular mechanisms of action of bisphosphonates.双膦酸盐的细胞和分子作用机制。
Cancer. 2000 Jun 15;88(12 Suppl):2961-78. doi: 10.1002/1097-0142(20000615)88:12+<2961::aid-cncr12>3.3.co;2-c.
7
Molecular basis of the spectrum of skeletal complications of neoplasia.
Cancer. 2000 Jun 15;88(12 Suppl):2903-8. doi: 10.1002/1097-0142(20000615)88:12+<2903::aid-cncr4>3.0.co;2-g.
8
Molecular mechanisms of osteolytic bone metastases.溶骨性骨转移的分子机制
Cancer. 2000 Jun 15;88(12 Suppl):2892-8. doi: 10.1002/1097-0142(20000615)88:12+<2892::aid-cncr2>3.0.co;2-y.
9
Bisphosphonates induce apoptosis in human breast cancer cell lines.双膦酸盐可诱导人乳腺癌细胞系发生凋亡。
Br J Cancer. 2000 Apr;82(8):1459-68. doi: 10.1054/bjoc.1999.1131.
10
Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF/TRANCE that induces osteoclast formation.
Biochem Biophys Res Commun. 2000 Mar 16;269(2):532-6. doi: 10.1006/bbrc.2000.2314.
Zotero 插件